d2cax41o7ahm5l.cloudfront.net · asif mahmood disease area cluster lead for biosimilars pfi zer,...
TRANSCRIPT
August 20-22, 2018 Tokyo, Japan
conferenceseries.com
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapaci� c
Participation200+ 15+
InteractiveSessions
10+KeynoteLectures
50+PlenaryLectures
10+Exhibitors
B2BMeetings
3+Workshops
August 20-22, 2018 Tokyo, JapanAugust 20-22, 2018 Tokyo, Japan
Invitation...Dear Colleagues,
Conference Series LLC extends its welcome to 9th Asian Biologics and Biosimilars Congress during August 20-22, 2018 at Tokyo, Japan with a theme “Biologics & Biosimilars: Power of the Past - Force of the Future”. Conference Series LLC through its Open Access Initiative is committed to make genuine and reliable contributions to the scientifi c community.
Conference Series LLC Organizes 1000+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientifi c societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board members.
The Asian Biosimilars Congress 2018 brings together biopharmaceutical. industry colleagues, scientists, researchers, regulatory, and clinical experts from around. the globe to bring to you the cutting edge information for the development of biologics and biosimilars and is designed to bring forth the most up to. date information for the development of biosimilars. World-renowned speakers, the. most recent research, advances, and the newest updates in Biologics and Biosimilars are hallmarks of this conference.
Join your peers from around the world for this wonderful opportunity to reach the. largest assembly of participants from the Biologics/Biosimilars community, meet with thought leadership experts, share your new research, and show off your cutting edge technology at this 3-day event.
Organizing Committee MembersAsif MahmoodDisease Area ClusterLead for BiosimilarsPfi zer, USA
Hossein PakdamanUniversity of MedicalSciencesTehran, Iran
Oxana IliachSr. Director Quintiles IMSCanada
Candida FratazziPresidentBBCR ConsultingUSA
Kamali ChanceVice PresidentQuintiles, IMS.USA
Raymond HumlVice PrecidentQuintiles IMSUSA
Charu ManaktalaSenior MedicalDirectorQuintiles IMS, India
Lutz HilbrichHead of BiosimilarsPlatformSanofi , China
Suzette DiMascioCEO & PresidentCSI Specialty GroupUSA
Divya Chadha ManekHead of CommercialBusiness NIHR, United Kingdom
Osama O. IbrahimBiotechnology/ FoodSafetyBioinnovation, USA
T. Santha RajuSr. Director & HeadMedImmune, USA
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapaci� c
* Exclusive Exhibitor Event | ** Networking EventNote: Conference schedule is subject to change.Note: Workshops and Symposia slots are available. To book slot for Workshop and Symposium send us the proposal.
Ten
tative
Age
nda August 20, 2018 Monday
Time Session08:30-09:30 Registrations09:30-11:30 Keynote Forum
Group Photo11:30-11:45 Network & Refreshments Break*
11:45-13:00Latest Biosimilars in Asian Scenario | Regulatory Approach for BiosimilarsChallenges in Developing Biosimilars
13:00-13:45 Lunch Break**13:45-16:00 Biosimilar Market and Cost Analysis | Pharmacovigilance of Biosimilars16:00-16:15 Network & Refreshments Break*16:15-18:00 Biosimilars Research Pipeline | Globalization of Biosimilars
August 21, 2018 TuesdayTime Session08:30-09:30 Registrations09:30-10:30 Keynote Forum10:30-11:30 Emerging Trends in Biosimilars | Clinical Studies on Biosimilars11:30-11:45 Network & Refreshments Break*11:45-13:00 Emerging Biosimilars in Therapeutics | Biosimilars Analytical Strategies13:00-13:45 Lunch Break**13:45-16:00 Legal Issues and BPCI Act | Intellectual Property Rights16:00-16:15 Network & Refreshments Break*16:15-18:00 Poster Presentations
August 22, 2018 WednesdayTime Session09:30-11:30 Brexit Effect on Biosimilars | BCS & IVIVC Based Biowaivers11:30-11:45 Network & Refreshments Break*11:45-13:00 Biosimilar Companies and Market Analysis | Bioequivalence Assessment13:00-13:45 Lunch Break**13:45-16:00 Entrepreneurs Investment Meet | Pharmacovigilance of Biosimilars16:00-16:15 Network & Refreshments Break*
Award Ceremony
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapaci� c
Con
feren
ce H
ighlig
hsts
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapaci� c
Track 1: Latest Biosimilars in Asian ScenarioTrack 2: Regulatory Approach for BiosimilarsTrack 3: Challenges in Developing BiosimilarsTrack 4: Biosimilar Market and Cost AnalysisTrack 5: Pharmacovigilance of BiosimilarsTrack 6: Biosimilars Research PipelineTrack 7: Globalization of BiosimilarsTrack 8: Emerging Trends in BiosimilarsTrack 9: Clinical Studies on BiosimilarsTrack 10: Emerging Biosimilars in TherapeuticsTrack 11: Biosimilars Analytical StrategiesTrack 12: Legal Issues and BPCI ActTrack 13: Intellectual Property RightsTrack 14: Brexit Effect on BiosimilarsTrack 15: BCS & IVIVC Based BiowaiversTrack 16: Biosimilar Companies and Market AnalysisTrack 17: Bioequivalence AssessmentTrack 18: Entrepreneurs Investment Meet
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapaci� c
Abdel Halim HarrathKing Saud UniversitySaudi Arabia
Alex BrillAmerican Enterprise Institute USA
Andy UpsallAntibody Analytics United Kingdom
Beat FluehmannVifor Pharma Switzerland
Christina VesselyBiologics Consulting, USA
Darius PanaliganMerck Biosimilars Switzerland
Fiona M GreerSGS Life Sciences United Kingdom
Gordon BolgerNucro-Technics Inc., Canada
James HarrisHealthcare Economics LLC USA
Kamali Chance Quintiles, IMSUSA
Lisa Mueller Women In BioUSA
Abe Hershkovitz Hershkovitz & Associates, PLLC USA
Alexander Pitters Kaiser Optical SystemsFrance
Angela FurlanettoDLA Piper (Canada) LLPCanada
Candida Fratazzi BBCR Consulting USA
Christoph VolpersMichalski & Hüttermann Germany
Denise Kettelberger Patterson Thuente Pedersen, P.A.,USA
Francesco MarchesiRegina Elena National Cancer Institute, Italy
Gregory Glover Principal at Pharmaceutical Law Group PCUSA
Jianguo Yang Abpro, USA
Kerisha Bowen Dentons US LLC USA
Luis UlloaRutgers University- New Jersey Medical School USA
Afshin Safavi BioAgilytix Labs USA
András Guttman University
Aparna Kasinath Syngene InternationalIndia
Charu Manaktala Quintiles IMSIndia
Chris LeintzPfi zerUSA
Dipti GulatiPJI BiotechUSA
Frank Cheng Alban Pharma China
Gustavo H. Marin UNLP-CONICET Argentina
Yahua (Jenny) Chen, Wolf, Greenfi eld & Sacks P.CUSA
Krishna Menon CellceutixUSA
Marcus Mreyen Protagen Protein Services, GmbH Germany
Alan L. Epstein USC Keck School of MedicineUSA
Andreu Soldevila LeanBioProSpain
Asif Mahmood Pfi zerUSA
Past Speakers
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapaci� c
Christelle Dagoneau Catalent Biologics USA
Daniel Galbraith BioOutsource Ltd United Kingdom
Divya Chadha Manek, NIHRUK
Gene Ransom CEO MedChi, The Maryland State Medical Society USA
Hossein Pakdaman, Iranian Neurological AssociationIran
Jill MyersFortress BiotechUSA
Laszlo Endrenyi University of TorontoCanada
Mariana Babayeva Touro College of PharmacyUSA
Mario DiPaola Blue Stream Laboratories, Inc, USA
Patrick Lucy Pfenex IncUSA
Robert Salcedo BioSciences Corp USA
Siddhartha Roy Bose InstituteIndia
Timothy Shea Sterne, Kessler, Goldstein & Fox P.L.L.C.,USA
Schellenberger Volker Schellenberger Amunix Operating Inc., USA
Mark Emalfarb Dyadic International, Inc., USA
Nigel Rulewski QuintilesUSA
Raj DavePillsbury Winthrop Shaw Pittman LLP USA
Ronald A Rader Biotechnology Information InstituteUSA
Subir RoyNovartisIndia
Tom CarverJ A Kemp - Patent and Trade Mark AttorneysUnited Kingdom
William Sarraille Sidley Austin LLP USA
Milind Antani Nishith Desai AssociatesIndia
Noelle Sunstrom NeuClone Pty Ltd, Australia
Raymond A Huml QuintilesIMSUSA
Ruediger Jankowsky, Cinfa Biotech GmbH, Germany
Samantha (Little) HowardCovance Clinical Research Unit, Inc., United Kingdom
UpendraNagaichAmity Institute of PharmacyIndia
Wolfgang RehmannTaylor Wessing Germany
Neil Schauer Schauer Biologics Consulting, LLC, USA
Min Zhang AstraZenecaUSA
Oxana Iliach Quintiles IMS Canada
Ricahrd Littlewood Appliedstrategic UK
Sarfaraz K. Niazi Adello Biologics LLCUSA
Sunit Maity Zumutor Biologics India
Vivek morya Centre for policy researchIndia
Zhaoyang LiSanofi USA
Tokyo is Japan’s capital and the largest metropolitan area in the world. It is also one of Japan’s 47 prefectures, consisting of 23 central city wards and multiple cities, towns and villages west of the city center. The Izu and Ogasawara Islands are also part of Tokyo. Prior to 1868, Tokyo was known as Edo. A small castle town in the 16th century, Edo became Japan’s political center in 1603 when Tokugawa Ieyasu established his feudal government there. A few decades later, Edo had grown into one of the world’s most populous cities. With the Meiji Restoration of 1868, the emperor and capital moved from Kyoto to Edo, which was renamed Tokyo (“Eastern Capital”).
World’s highest Skywalk- the Tokyo Sky tree is the tallest free-standing tower in the world, measuring 634m. The observation deck at 450m is the world’s highest skywalk and offers panoramic views of the city.
Tokyo is a fascinating city, where the latest trends and the oldest traditions meet. From ancient cherry-blossomfestivals to the vibrant Harajuku neighbourhood, Tokyo offers a seemingly unlimited choice of shopping, entertainment, culture and dining to its visitors.
The city’s history can be appreciated in districts such as Asakusa, and in many excellent museums, historic temples and gardens. Contrary to common perception, Tokyo also offers a number of attractive green spaces in the city centre and within relatively short train rides at its outskirts.
You’ll fall in love with Japan
Venue:
Radisson Narita, Tokyo 650-35 Nanae, Tomisato-Shi
Narita 286-0221, Japan
Mail us to know more!For Abstract Submission Guidelines | For Reserving your slot | Proposals | Registration | Posters | Accommodations
No doubt you have lots of queries... Why not get in touch..!
Drop us your query with details and we will call you right away
Venue
For Queries Contact: Victorya Jones | Program Director
Email: [email protected] ce Ph: +1-650-889-4686 Ext: 6093
Toll No: +1-800-216-6499 (USA & Canada)
For Exhibition & Sponsorship Contact: Victorya Jones
Email: [email protected]
Hosted by Conference Series Ltd.One Commerce Center-1201
Orange St. #600, Wilmington, Zip 19899, Delaware, USA
Toll Free: [email protected]
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapaci� c